AERI
Aerie Pharmaceuticals Inc
Ophthalmic pharmaceutical company focused on discovery, development and commercialization of first-in-class ophthalmic therapies
CUSIP: 00771V108HealthcareUS1 holder
Total Value
$77.0K
Total Shares
6.7K
Net Share Change
-28.5K
Activity
1 selling
Investor
Value
Shares
Weight
Change
Maverick Capital
$77.0K6.7K shares
TRIM-28.5K(-80.9%)